Jazz Pharmaceuticals (NASDAQ: JAZZ) Form 144: 10,116 restricted shares; insider sold 2,238

Rhea-AI Filing Summary

Jazz Pharmaceuticals submitted a Form 144 notice regarding proposed issuance/sale of restricted common stock as compensation. The filing lists 10,116 restricted common shares tied to 02/26/2026 and labels the transaction type as compensation.

The filing also reports a prior sale: Mary Elizabeth Henderson sold 2,238 common shares on 12/09/2025 for $379,365. The document otherwise provides standard Form 144 disclosure items for an issuer-related restricted stock transaction.

Insights

Corporate Governance Analyst

Form 144 records a planned issuer-side restricted-stock distribution and a recent insider sale.

The filing lists 10,116 restricted common shares associated with compensation and dated 02/26/2026

Mary Elizabeth Henderson's prior sale of 2,238 shares on 12/09/2025 for $379,365 is reported. Timing and pricing mechanics for the planned restricted-share distribution are not detailed in this excerpt; subsequent filings may disclose settlement or trading details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	10116	1991132.28	61560350	02/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	02/26/2026	RESTRICTED STOCK	ISSUER			10116	02/26/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mary Elizabeth Henderson FIFTH FLOOR, WATERLOO EXCHANGEWATERLOO R DUBLIN L2 04E5W7	Common	12/09/2025	2238	379365.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Jazz's Form 144 disclose about the proposed restricted stock?

It discloses a proposed issuance/sale of 10,116 restricted common shares tied to compensation dated 02/26/2026. The filing labels the securities as restricted stock and classifies the transaction as issuer compensation.

Who sold shares previously according to this filing for JAZZ?

Mary Elizabeth Henderson sold 2,238 common shares on 12/09/2025 for $379,365. That sale is reported under the "Securities Sold During The Past 3 Months" section of the Form 144 excerpt.

Does the Form 144 show how proceeds from the restricted shares will be used by Jazz?

No use-of-proceeds information is included in the provided excerpt. The filing identifies the shares as compensation, but it does not state any cash-proceeds allocation or recipient details beyond the compensation label.

Are the restricted shares in the filing immediately tradable upon filing?

The excerpt lists the securities as restricted stock and ties them to a 02/26/2026 compensation event. The filing does not state whether the shares are immediately tradable or subject to vesting or resale conditions.